Valuation: IDEXX Laboratories, Inc.

Market Cap 54.99B 49.9B 46.1B 41.63B 78.46B 5,182B 81.22B 554B 219B 2,769B 206B 202B 8,782B P/E 2026 *
46.3x
P/E 2027 * 41.5x
Enterprise Value 55.35B 50.22B 46.4B 41.9B 78.97B 5,216B 81.75B 558B 221B 2,787B 208B 203B 8,839B EV / Sales 2026 *
11.6x
EV / Sales 2027 * 10.6x
Free-Float
72.24%
Yield 2026 *
-
Yield 2027 * -
1 day+0.89%
1 week+5.00%
Current month+27.76%
1 month+34.41%
3 months+23.42%
6 months+31.90%
Current year+4.09%
1 week 680
Extreme 680
712.88
1 month 518.84
Extreme 518.835
713.74
Current year 500.61
Extreme 500.61
726.41
1 year 500.61
Extreme 500.61
769.98
3 years 356.14
Extreme 356.14
769.98
5 years 317.06
Extreme 317.06
769.98
10 years 108.99
Extreme 108.99
769.98
Manager TitleAgeSince
Chief Executive Officer 52 2026-05-11
Director of Finance/CFO 43 2025-02-28
Chief Operating Officer 58 2024-12-31
Director TitleAgeSince
Chairman 65 2026-05-11
Director/Board Member 64 2013-07-14
Director/Board Member 73 2014-03-10
Date Insider Type Main position Quantity % Market Cap. Importance
11/4/26 Sell

Director

-1,200 0.0015%
11/4/26 Exercice

Chairman

75,420 0.0957%
11/4/26 Sell

Executive/Senior Manager

-3,979 0.0051%
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%+5.00%-1.31%+64.26% 54.99B
+1.18%-4.47%-15.76%+15.48% 186B
+1.85%-1.89%+7.36%+45.53% 124B
-0.88%-7.59%-15.71%+13.16% 119B
+1.36%-5.00%-43.14%+4.26% 91.43B
+2.96%+5.70%-1.21%+81.72% 66.67B
+1.08%+2.10%+13.49%-7.08% 58.76B
-0.68%-0.62%-2.41%+56.27% 49.93B
-1.28%-0.73% - - 35.13B
+1.79%-2.26%-4.21%-5.51% 34.69B
Average +0.83%-2.18%-6.99%+29.79% 82B
Weighted average by Cap. +0.93%-3.39%-9.50%+27.58%

Financials

2026 *2027 *
Net sales 4.76B 4.32B 3.99B 3.6B 6.78B 448B 7.02B 47.92B 18.96B 239B 17.85B 17.47B 759B 5.18B 4.7B 4.34B 3.92B 7.39B 488B 7.65B 52.17B 20.64B 261B 19.43B 19.02B 827B
Net income 1.2B 1.09B 1B 906M 1.71B 113B 1.77B 12.06B 4.77B 60.27B 4.49B 4.4B 191B 1.32B 1.2B 1.11B 1B 1.89B 125B 1.95B 13.33B 5.27B 66.61B 4.97B 4.86B 211B
Net Debt 358M 324M 300M 271M 510M 33.69B 528M 3.6B 1.43B 18B 1.34B 1.31B 57.1B -178M -162M -149M -135M -254M -16.79B -263M -1.79B -710M -8.97B -669M -654M -28.45B
Projected Income Statement - Annual - IDEXX Laboratories, Inc.
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
26-11-13 $704.31 +0.90% 392,309
26-11-12 $698.02 -0.65% 487,643
26-11-11 $702.59 +0.85% 423,320
26-11-10 $696.64 -1.42% 463,972
26-11-09 $706.65 +4.53% 703,732
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - IDEXX Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
704.31USD
Average target price
717.17USD
Spread / Average Target
+1.83%
  1. Stock Market
  2. Stocks
  3. IDXX Stock